Sofia, Bulgaria, December 6, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for November 2021 the Company recorded a decrease in sales of 9% compared to the same month of the previous year, incl. 42% increase in domestic sales and 25% decrease in export sales.

Sofia, Bulgaria, December 6, 2021 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD notifies that on December 3, 2021 the Company bought 143 533 own shares representing 1.1065% of the share capital of the Company, at a total value of BGN 631 545,20 on the Bulgarian Stock Exchange, the average price per share was 4.400 BGN.

The total number of treasury shares after this transaction is 13 055 000, representing 9.685% of the share capital of the Company.

Sofia, Bulgaria, December 2, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD  notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para.

Sofia, Bulgaria, December 2, 2021 - According to art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, Sopharma AD notifies that on December 1, 2021 the Company bought 2 600 000 own shares representing 1.9288% of the share capital of the Company, at a total value of BGN 11 076 000 on the Bulgarian Stock Exchange, the average price per share was 4.260 BGN.

The total number of treasury shares after this transaction is 12 911 467, representing 9.578% of the share capital of the Company.